4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-039715
Chief Executive Officer sold 6,400 shares at an average $39.60 ($253,425)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2018-06-26 | Sale | −2,700 | $40.01 | $108,027 | 159,778 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-06-26 | Sale | −1,700 | $40.79 | $69,343 | 158,078 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-06-27 | Sale | −1,500 | $37.57 | $56,355 | 156,578 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-06-27 | Sale | −500 | $39.40 | $19,700 | 156,078 | I |
| Open-market sales · 6,400 sh · avg $39.60 · $253,425 | |||||||
Loading xslF345X03/doc4.xml…